Research

Providence Multiple Sclerosis Center

Clinical trials: Multiple sclerosis

Useful therapies are available for virtually every patient with multiple sclerosis. FDA-approved medications currently in use have had major beneficial impact on disease activity in many patients, but we must do better. We must develop therapies with even more potency in disease control, less potential of toxicity and improved ease of administration and patient comfort. More »